Adele Busico

Milan, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 70 publications

Assessing in house comprehensive genomic profiling by liquid biopsy for NSCLC patients.

Assessing in house comprehensive genomic profiling by liquid biopsy for NSCLC patients.

Journal: Tumori
Published: June 24, 2026

Lynch syndrome-associated urothelial carcinoma: clinical and molecular findings from a single-institution cohort.

Lynch syndrome-associated urothelial carcinoma: clinical and molecular findings from a single-institution cohort.

Journal: Familial cancer
Published: June 01, 2026

Comprehensive genomic profiling of mucosal melanoma reveals novel fusion transcripts and dysregulation of cell-cycle, MAPK, and PI3K pathways.

Comprehensive genomic profiling of mucosal melanoma reveals novel fusion transcripts and dysregulation of cell-cycle, MAPK, and PI3K pathways.

Journal: The Journal of pathology
Published: January 15, 2026

Re-treatment with panitumumab followed by regorafenib versus the reverse sequence in chemorefractory metastatic colorectal cancer patients with RAS and BRAF wild-type circulating tumor DNA: the PARERE study by GONO.

Re-treatment with panitumumab followed by regorafenib versus the reverse sequence in chemorefractory metastatic colorectal cancer patients with RAS and BRAF wild-type circulating tumor DNA: the PARERE study by GONO.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: September 05, 2025

A tailored histology-driven molecular profiling algorithm proposal for salivary gland cancers.

A tailored histology-driven molecular profiling algorithm proposal for salivary gland cancers.

Journal: ESMO open
Published: August 09, 2025

Validating HER2 copy number variation assessment by NGS: A comparative analysis with immunohistochemistry and in situ hybridization.

Validating HER2 copy number variation assessment by NGS: A comparative analysis with immunohistochemistry and in situ hybridization.

Journal: Tumori
Published: July 09, 2025

Real-World Outcomes of Molecular Tumor Board Treatment Recommendations.

Real-World Outcomes of Molecular Tumor Board Treatment Recommendations.

Journal: JCO precision oncology
Published: June 11, 2025

Genomic instability and CCNE1 amplification as emerging biomarkers for stratifying high-grade serous ovarian cancer.

Genomic instability and CCNE1 amplification as emerging biomarkers for stratifying high-grade serous ovarian cancer.

Journal: Frontiers in oncology
Published: May 22, 2025

Impact of comprehensive genomic profiling and molecular tumour board on costs and access to tailored therapies: real-world observational study.

Impact of comprehensive genomic profiling and molecular tumour board on costs and access to tailored therapies: real-world observational study.

Journal: BMJ open
Published: May 16, 2025

Harmonization trial of FGFR1-3 testing strategies in cholangiocarcinoma patients: an Italian multicenter experience.

Harmonization trial of FGFR1-3 testing strategies in cholangiocarcinoma patients: an Italian multicenter experience.

Journal: Pathologica
Published: May 13, 2025

Circulating tumor DNA to anticipate loco-regional recurrence in early-stage breast cancer: a proof-of-concept study.

Circulating tumor DNA to anticipate loco-regional recurrence in early-stage breast cancer: a proof-of-concept study.

Journal: Frontiers in oncology
Published: April 30, 2025

Refining High-Risk EGFR-Mutant Lung Cancer Patients: The Role of Adjusted Variant Allele Frequency in First-Line Osimertinib Therapy.

Refining High-Risk EGFR-Mutant Lung Cancer Patients: The Role of Adjusted Variant Allele Frequency in First-Line Osimertinib Therapy.

Journal: Clinical lung cancer
Published: April 14, 2025
Showing 1-12 of 70

Last Updated: 09/26/2026